Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells

Jie Li(Wenzhou Medical University), Liying Xue(Hebei Medical University)
Molecular Medicine Reports
February 24, 2021
Cited by 18


Related Papers